Mouli Samdeep K, Gupta Ramona, Sheth Neil, Gordon Andrew C, Lewandowski Robert J
Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois.
Division of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, Illinois.
Semin Intervent Radiol. 2018 Mar;35(1):29-34. doi: 10.1055/s-0038-1636518. Epub 2018 Apr 5.
Breast cancer is the most common women's malignancy in the United States and is the second leading cause of cancer death. More than half of patients with breast cancer will develop hepatic metastases; this portends a poorer prognosis. In the appropriately selected patient, there does appear to be a role for curative (surgery, ablation) or palliative (intra-arterial treatments) locoregional therapy. Gynecologic malignancies are less common and metastases to the liver are most often seen in the setting of disseminated disease. The role of locoregional therapies in these patients is not well reported. The purpose of this article is to review the outcomes data of locoregional therapies in the treatment of hepatic metastases from breast and gynecologic malignancies.
乳腺癌是美国女性中最常见的恶性肿瘤，也是癌症死亡的第二大主要原因。超过一半的乳腺癌患者会发生肝转移；这预示着预后较差。在适当选择的患者中，根治性（手术、消融）或姑息性（动脉内治疗）局部区域治疗似乎确实有作用。妇科恶性肿瘤不太常见，肝转移最常出现在播散性疾病的情况下。局部区域治疗在这些患者中的作用报道较少。本文的目的是回顾局部区域治疗在乳腺癌和妇科恶性肿瘤肝转移治疗中的疗效数据。
